Tenaya Therapeutics (TYNA) IPO Opens 30% Higher

Today's IPO for Tenaya Therapeutics, Inc. (NASDAQ: TNYA) opened for trading at $19.50 after pricing its upsized initial public offering of 12,000,000 shares of its common stock at an initial public offering price of $15.00 per share. The company was planning to offer 10,000,000 shares at $14-$16.

The joint book-running managers for the offering were Morgan Stanley, Cowen and Piper Sandler. Chardan is acting as lead manager for the offering.

Tenaya Therapeutics is a biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center, Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine.

You May Also Be Interested In

• SpaceX held talks to acquire AI coding startup Cognition - report
• Eightco reports $389M in holdings, repurchases 14M shares
• K Wave Media prices $1M registered direct offering at $1.90 per share